Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation

Clinical trial NCT06735664 · RECRUITING

Trial details

NCT number: NCT06735664
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Transformed Chronic Lymphocytic Leukemia Refractory Transformed Chronic Lymphocytic Leukemia Richter Syndrome Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma

Start date: 2025-08-14
Primary completion: 2027-12-13
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.